Chemistry - A European Journal · 2018 · 52 citations · 28 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryNeuropharmacologyPsychopharmacologyAntidepressant PharmacologyFungal Natural Product BiosynthesisNovel Psychoactive SubstancesFungal Bioactive Compounds
The fungal genus Psilocybe and other genera comprise numerous mushroom species that biosynthesize psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine). It represents the prodrug to its dephosphorylated psychotropic analogue, psilocin. The colloquial term "magic mushrooms" for these fungi alludes to their hallucinogenic effects and to their use as recreational drugs. However, clinical trials have recognized psilocybin as a valuable candidate to be developed into a medication against depression and anxiety. We here highlight its recently elucidated biosynthesis, the concurrently developed concept of enzymatic in vitro and heterologous in vivo production, along with previous synthetic routes. The prospect of psilocybin as a promising therapeutic may entail an increased demand, which can be met by biotechnological production. Therefore, we also briefly touch on psilocybin's therapeutic relevance and pharmacology.
28
Drug harms in the UK: a multicriteria decision analysis
David Nutt, Leslie A. King, Lawrence D. Phillips · The Lancet · 2010 · 1.7K citations
Yeast gene TRP5: structure, function, regulation.
H Zalkin, Charles Yanofsky · Journal of Biological Chemistry · 1982 · 238 citations · Full text
Enzymatic Synthesis of Psilocybin
Janis Fricke, Felix Blei, Dirk Hoffmeister · Angewandte Chemie International Edition · 2017 · 207 citations